Europe

Jan 17, 2017
The long-cherished dream of finding a European approach to assessing the value of new medicines seems to recede further with every step taken to pursue it, writes Reflector.
Jan 10, 2017
The Lancet's series of papers on moving from universal health care to "right care" for health offers a global and comprehensive perspective, writes Leela Barham. But what does "right care" mean for the industry?
Dec 21, 2016
2016 has been the year of the unpredictable — and the uncertainties this has generated will multiply and dominate the agenda in Europe in 2017, writes Reflector.
Dec 06, 2016
Leela Barham speaks to NICE International and Imperial College’s Institute of Global Health Innovation about joining forces under the International Decision Support Initiative.
Nov 29, 2016
The European Medicine Association is determined keep open all options on the future of drug approvals in advance of a crucial meeting in December, writes Reflector.
Nov 25, 2016
The UK's NICE, like the NHS it supports, is looking at how to make big savings. One option is to get more "commercial". Leela Barham takes a look.
Nov 05, 2016
Leela Barham looks at the 18 recommendations of England’s Accelerated Access Review (AAR), which proposes how to speed up adoption of the best innovation in the NHS.
Oct 20, 2016
Leela Barham looks at NICE's latest proposals aimed at tackling the affordability challenge.
Oct 19, 2016
Cancer treatment is an increasing dilemma for health services as they try to balance patient care against budgetary constraints.
Oct 12, 2016
Pharmaceutical Executive
The potential collapse of the CETA agreement jeopardizes EU’s overall trade footing.
native1_300x100
lorem ipsum